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Who should read this paper?
This paper represents a summary review of the state of the art in
extracting nutraceuticals (any substance that may be considered a food
or part of a food and provides medical or health benefits, including the
prevention and treatment of disease - Foundation for Innovation and
Medicine) from the sea. Anyone with an interest in where omega-3 fatty
acids and a range of other healthful products (for example, glucosamine)
come from, and where new breakthroughs are possible, will be
interested in reading this paper.
Why is it important?
The beneficial health effects of fish and other seafood are being
increasingly recognized by medical researchers and the general public
alike. The benefits of fish oils alone include combating coronary heart
disease, and assisting with visual and cognitive development, psychiatric
disorders, inflammatory diseases, Crohn’s disease and type 2 diabetes,
among others. Meanwhile, unexploited resources from the oceans offer
many opportunities for future developments. For example, there is a
great deal of interest in seaweed because of evidence linking habitual
consumption of seaweed to reduced risk of a number of chronic
diseases in some Asian populations.
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ABSTRACT 
Marine, fresh water and cultured fish, shellfish and other aquatic species provide a rich source of food as 
well as by-products that could be used for production of a wide range of health promoting compounds.  These 
bioactives include omega-3 fatty acids, proteins and biopeptides, carotenoids and carotenoproteins, enzymes, 
chitinous materials and glucosamine as well as minerals, among others.  The bioactives present in seafoods 
and aquatic resources are effective in rendering beneficial health effects and reducing the risk of a number of 
chronic diseases.  Thus, such bioactives may serve as important value-added nutraceuticals, natural health 
products and functional food ingredients that can be used for health promotion and disease risk reduction. 
INTRODUCTION 
Seafood products such as fish, shellfish and 
molluscs have traditionally been used because of their 
variety of flavor, colour, texture and accessibility in the 
coastal areas.  More recently, seafoods are 
appreciated because of the emergence of new  
Figure 1a: Landing of fish 
Figure 1b: Shellfish used as food 
evidence about their role in health promotion and 
disease risk reduction, primarily arising from their 
bioactive omega-3 fatty acids, among others.  
Nutraceuticals and healthful products from aquatic 
resources belong to several classes of compounds and 
are used in foods and natural health products (see 
Table 1).  A large proportion of by-products, up to 
75%, and low-value fish is also procured as a result of 
processing and harvesting.  Figure 1 provides a 
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Table 1. Nutraceuticals and natural health products for marine resources
Components Application Area
Chitin, chitosin, chitosan, oligomer, 
glucosamine 
Food, water and juice clarification, agriculture, supplements 
Omega-3 oils Nutraceuticals, immune enhancement, CVD, others 
Chonodostin sulfate Dietary supplement, arthritic pain 
Squalene Skin care 
Biopeptides, collagen and protein Nutraceuticals, immune enhancement, etc. 
Carotenoids and Carotenoprotein Nutraceuticals, others. 
Minerals (calcium) Nutraceuticals 
Enzymes Food and speciality application, others 
Other specialty chemicals Miscellaneous  
graphic representation of harvest of fish and the 
variety of shellfish that are generally used as food. 
Figure 2 shows processing of fish for food in an 
industrial setting.  The components of interest that 
could be extracted or produced from marine resources 
include lipids, proteins and biopeptides, minerals, 
flavorants, carotenoids and carotenoproteins, 
enzymes, chitinous materials and other specialty 
products.  The importance of omega-3 fatty acids, 
bioactive peptides, glucosamine, chitosan and 
chitosan oligomers and other bioactives in food and 
non-food applications as well as for health promotion 
purposes has been well recognized.  This overview 
provides a cursory account of selected bioactives from 
aquatic resources. 
OMEGA-3 FATTY ACIDS AND NUTRACEUTICAL LIPIDS 
The occurrence and health benefits of long-chain 
omega-3 polyunsaturated fatty acids (PUFA) in aquatic 
organisms is a well known [Simopoulos, 1991; 
Abeywardena and Head, 2001; Shahidi and Kim, 
2002].  These fatty acids are produced in 
phytoplanktons in the oceans and are then consumed 
by fish and other aquatic species directly, or indirectly 
assimilated through the trophic levels of the food 
chain, e.g. top predators including marine mammals 
and tunas. Thus, omega-3 PUFA may be procured 
from algae, body of fatty fish, liver of white lean fish 
and the blubber of marine mammals.  The constituent 
fatty acids present in such oils include 
eicosapentaenoic acid (EPA, C20:5n-3), 
docosahexaenoic acid (DHA, C22:6n-3; Figure 3), 
and, to a lesser extent, docosapentaenoic acid (DPA, 
C22:5n-3) in different proportions, depending on the  
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Figure 2: Processing of fish for separation of fillets and other edible parts. 
Figure 3: Molecular model representation of 
docosahexaenoic acid (DHA) 
species involved.  In addition, liver oil from white lean 
fish and shark serves as an excellent source of vitamin 
A and/or squalene and other bioactives. 
Table 2 summarizes the fatty acid composition of 
selected oils from aquatic species and an algal oil 
produced commercially.  As can be seen, the contents 
of EPA, DHA and DPA in each oil depends on the 
source material.  Thus the ratio of EPA to DHA in 
menhaden, cod liver and seal blubber oils varies 
considerably, but the algal oil tested almost exclusively 
contained DHA.  Furthermore, positional distribution of 
omega-3 fatty acids in such oils, again, depends on 
source material.  The omega-3 fatty acids are 
primarily located in the sn-2 position of triacylglycerols 
in fish while they are present mainly in the sn-1 and 
sn-3 positions of seal blubber oil. 
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Table 2. Major fatty acids of omega-3 rich marine and algal oilsa
Fatty acid Menhaden Cod liver Seal blubber Algal 
14:0 
16:0 
16:1 n-7 
18:0 
18:1 n-9, n-11 
20: n-9 
20:5 n-3 
22:1 n-11 
22:5 n-3 
22:6 n-3 
8.32 
17.4 
11.4 
3.33 
12.1 
1.44 
13.2 
0.12 
2.40 
10.1 
3.33 
11.0 
7.85 
3.89 
21.2 
10.4 
11.2 
9.07 
1.14 
14.8 
3.73 
5.58 
18.0 
0.88 
26.0 
12.2 
6.41 
2.01 
4.66 
7.58 
14.9 
9.05 
2.20 
0.20 
18.9 
-
-
-
0.51 
47.4 
a Units are weight percentage of total fatty acids; algal oil is DHASCO (docosahexaenoic acid single cell oil). 
Fish and other marine organism derived oils, 
similar to other edible oils, are subjected to different 
processing steps of refining, bleaching and 
deodorization.  As protective components of oils are 
generally removed to a large extent during processing, 
it is important to treat the resultant refined, bleached 
and deodorized (RBD) oils with appropriate 
antioxidants in order to enhance their oxidative 
stability.  Encapsulation and microencapsulation 
provide other means for extending the shelf-life of 
highly unsaturated oils.  Regardless, such oils increase 
the body demand for vitamin E (1).  Therefore, addition 
of vitamin E, usually in the form of mixed tocopherols, 
to highly unsaturated oils is necessary for enhancing 
their oxidative stability and also to augment the body’s 
need for vitamin E. 
The use of fish oils containing omega-3 fatty 
acids is recommended for foods that are used within a 
short period of time in order to avoid possible off- 
flavor development during their expected shelf-life.  
While it is possible to mask some of the off-flavors 
generated due to production of flavor-active secondary 
oxidation products, presence of primary products of 
oxidation remains to be a concern.  Another way of 
introducing omega-3 fatty acids into food products is 
to employ adequately microencapsulated products that 
may remain intact until they reach the gastrointestinal 
tract.  In this way, there is no flavor effect on the 
product even if the oil used initially contained some 
oxidation products.  The techniques used for this 
purpose include multi-layer coaservation employed by 
Ocean Nutrition Canada.  Table 3 summarizes a 
number of food products that are usually selected to 
enrich them with omega-3 oils. 
Table 3. Food application of omega-3 oils
Bread/bread products Margarine and spreads 
Cereals, crackers, noodles Eggs 
Pasta and cakes Bars and candies 
Milk and dairy products Infant formula 
Juices Fabricated seafoods, 
burgers, etc. 
Mayonnaise and salad 
dressings 
Others 
The beneficial health effects of fish and other 
highly unsaturated oils are manifold and include 
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coronary heart disease (CHD), visual and cognitive 
development, psychiatric disorders inflammatory 
diseases, Crohn’s disease and type 2 diabetes, among 
others.  The omega-3 fatty acids, especially DHA 
(Figure 3), are known to dominate the fatty acid profile 
of brain and retina lipids and play a major role in the 
development of the fetus and infants as well as health 
status and body requirement of pregnant and lactating 
women.  Both EPA and DHA have been suggested to 
affect brown fat pad and lead to weight loss.  
However, more research in this area may be required. 
For therapeutic purposes, the natural sources of 
omega-3 fatty acids as such may not provide the 
necessary amount of these fatty acids and hence 
production and use of omega-3 concentrates may be 
required [Wanasundara et al, 2002].  The omega-3 
concentrates may be produced in the free fatty acid, 
simple alkyl ester, and acylglycerol forms.  To achieve 
this, physical, chemical and enzymatic processes may 
be employed for concentrate production.  The 
available methods suitable for this purpose, on an 
industrial scale, are low-temperature crystallization, 
fractional or molecular distillation, urea complexation, 
chromatography, supercritical fluid extraction, and 
enzymatic splitting, among others [Wanasundara and 
Shahidi, 1997].  These procedures have been used, 
albeit to different extent, by the industry to prepare 
concentrates that are often sold in the ethyl ester form 
or re-esterified with glycerol to be offered as 
triacylglycerols to the market.  However, it has been 
demonstrated that acylglycerols are more stable than 
their corresponding ethyl esters.  Regardless, the 
modified oils need to be stabilized using synthetic or 
preferably natural antioxidants. 
In preparation of modified lipids containing 
omega-3 fatty acids, structured lipids (SL) may be 
produced.  SL are triacylglycerols (TAG) or 
phospholipids (PL) containing combinations of short-
chain, medium-chain and long-chain fatty acids 
(SCFA, MCFA and LCFA, respectively) located in the 
same molecule and may be produced by chemical or 
enzymatic means [Lee and Akah, 1998; Senenayake 
and Shahidi, 2000].  Structured lipids are developed to 
fully optimize the benefits of their fatty acid 
constituents in order to affect metabolic parameters 
such as immune function, nitrogen balance, and lipid 
clearance from the bloodstream.  These specialty 
lipids may be produced via direct esterification, 
acidolysis and hydrolysis or interesterification.  We 
have used the acidolysis process to incorporate capric 
acid or lauric acid into seal blubber oil [Senenayake 
and Shahidi, 2002; 2007].  In addition, we produced 
91% gamma-linolenic acid (GLA) concentrate from 
borage oil [Spurvey and Shahidi, 2000] which was 
subsequently used in acidolysis of menhaden and seal 
blubber oils [Spurvey et al, 2001].  Such structured 
lipids that include GLA, EPA and DHA were also 
prepared using borage and evening primrose as a 
source of GLA and acidolysis with EPA and/or DHA 
[Senenayake and Shahidi, 1999a; 1999b].  The 
products so obtained, while similar to those produced 
by incorporation of GLA into marine oils, differ in the 
composition and distribution of fatty acids involved. 
PEPTIDES AND PROTEINS FROM AQUATIC RESOURCES 
Proteins from aquatic resources are well-
balanced in their amino acid composition and hence 
are quite important dietary sources.  Proteins may be 
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Table 4 . Antioxidative peptides from Alaska pollock skin hydrolyzate and Soy 75 Proteina
Peptide Amino acid sequence 
Alaska Pollock
P1
P2
Gly-Glu-Hyp (Gly-Pro-Hyp)3-Gly
(Gly-Pro-Hyp)4-Gly
Soy 75 Protein
P1
P2
P3
P4
P5
P6
Val-Asn-Pro-His-Asp-His-Glu-Asn 
Leu-Val-Asn-Pro-His-Asn-His-Glu-Asn
Leu-Leu-Pro-His-His
Leu-Leu-Pro-His-His-Ala-Asp-Ala-Asp-Tyr
Val-Ile-Pro-Ala-Gly-Tyr-Pro 
Leu-Gly-Ser-Gly-Asp-Ala-Leu-Arg-Val-Pro-Ser-Gly-Thr-Tyr-
Tyr 
hydrolyzed to produce peptides with different 
numbers of amino acids as well as free amino acids.  
While enzymes with endopeptidase activity provide 
peptides with different chain lengths, exopeptidases 
liberate amino acids from the terminal positions of the 
protein molecules.  Depending on reaction variables as 
well as the type of enzyme, the degree of hydrolysis of 
proteins may differ considerably.  The peptides 
produced from the action of a specific enzyme may be 
subjected to further hydrolysis by other enzymes.  
Thus, use of an enzyme mixture or several enzymes in 
a sequential manner may be advantageous.  The 
peptides so obtained may be subjected to 
chromatographic separation and then evaluated for 
their amino acid sequence as well as their antioxidant 
and other activities. 
In a study on capelin protein hydrolysates, four 
peptide fractions were separated using Sephadex G-
10.  While one fraction exerted a strong antioxidant 
activity in a E-carotene/ linoleate model system, two 
fractions possessed a weak antioxidant activity and 
the fourth one had a prooxidant effect.  Two 
dimensional HPLC separation showed spots with both 
pro- and antioxidant effects [Amarowicz and Shahidi, 
1997].  Meanwhile, protein hydrolysates prepared 
from seal meat were found to serve as phosphate 
alternatives in processed meat applications and 
reduced the cooking loss considerably [Shahidi and 
Synowiecki, 1997].  Furthermore, Alaska pollock skin 
hydrolysate was prepared using a multienzyme system 
in a sequential manner.  The enzymes used in the 
order of application were Alcalase, Pronase E, and 
collagenase.  The fraction from the second step, 
which was hydrolyzed by Pronase E, was composed of 
peptides ranging from 1.5 to 4.5 kDa and showed a 
high antioxidant activity.  Two peptides were isolated 
using a combination of chromatographic procedures, 
and these were composed of 13 and 16 amino acid 
residues [Kim et al, 2001].  The sequence of the 
peptides involved is given in Table 4 and compared 
with those of soy 7S protein hydrolysates [Chen et al, 
1994].  These peptides exert their antioxidant activity 
via free radical scavenging as well as chelation effects 
and also possessed ACE (amgiotensin converting 
enzyme) inhibitory activity.  Recently, proteases from 
shrimp processing discards were characterized [Heu 
et al, 2003] and application of salt-fermented shrimp 
byproduct sauce as a meat tenderizer was reported 
[Kim et al, 2005]. 
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CHITIN, CHITOSAN, CHITOSAN OLIGOMERS AND 
GLUCOSAMINE 
Processing discards of shrimp, crab, lobster, and 
crayfish contain a sizable proportion of chitin that may 
be recovered following deproteinization and 
demineralization [Shahidi and Synowiecki, 1991].  The 
chitin so obtained may then be deacetylated to afford 
chitosan [Shahidi and Synowiecki, 1991].  Depending 
on the duration of the deacylation process, the 
chitosan produced may assume different viscosities 
and molecular weights.  Chitosans are soluble in weak 
acid solutions, thus chitosan ascorbate, chitosan 
acetate, chitosan lactate, and chitosan malate which 
are all water soluble may be obtained.  Chitosan has a 
variety of health benefits and may be employed in a 
number of nutraceutical and health-related 
applications in agriculture, water purification and 
health promoting commodities [Jeon et al, 2002; 
Kamil et al, 2002; Shahidi et al, 2002; Jeon et al, 
2000].  Chitosan derivatives may also be produced in 
order to obtain more effective products for certain 
applications.  Chitin and chitosan may be used for 
juice clarification, water purification and for odor 
removal, among other industrial applications.  
Chitosans may also be used for controlled release of 
nutrients and bioactives in both agricultural and 
pharmaceutical applications. 
Chitosans with different molecular weights and 
viscosities have been prepared and used to protect 
both raw and cooked fish against oxidation as well as 
microbial spoilage [Jeon et al, 2002; Kamil et al, 
2002; Shahidi et al, 2002].  The content of propanal, 
an indicator of oxidation of omega-3 fatty acids, was 
decreased when chitosan was used as an edible 
invisible film in herring.  Furthermore, the effects were 
more pronounced as the molecular weight of the 
chitosan increased.  In addition, inhibitory effects of 
chitosan coatings in the total microbial counts for cod 
and herring showed an approximately 1.5 and 2.0 log 
cycles difference between coated and uncoated 
samples, respectively, after 10 days of refrigerated 
storage (results not shown).  However, to have the 
products solubilized in water without the use of acids, 
enzymatic processes may be carried out to produce 
chitosan oligomers.  Due to their solubility in water, 
chitosan oligomers serve best in rendering their 
benefits under normal physiological conditions and in 
foods with neutral pH. Furthermore, depending on the 
type of enzyme employed, chitosan oligomers with 
specific chain lengths may be produced for certain 
applications [Jeon et al, 2000]. 
The low-molecular-weight chitin and chitosan 
oligomers (also known as chitin/chitosan 
oligosaccharides (COS’s) have received considerable 
attention as physiologically functional materials having 
antitumor, immuno-enhancing and antibacterial 
activities [Jeon and Kim, 2002; Tsukada et al, 1990; 
Jeon et al, 2001].  Production of COS’s via the 
hydrolysis of chitosan may be achieved chemically or 
enzymatically.  The enzymatic production is preferred, 
but cost of enzyme may be prohibitive.  Therefore, a 
continuous low cost production method to produce 
COS’s with desired molecular size has been developed 
[Jeon and Kim, 2000].  The COS’s (Table 5) with low-
molecular weight and hetero-chitosan 
oligosaccharides, have been reported to have 
antibacterial, free radical scavenging, ACE inhibitory 
and anticoagulant activities [Park et al, 2004].  The  
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Table 5. Antibacterial Activity of Different Molecular Weight Chitosan Oligosaccharide (COS) Fractions
Antibacterial activity (%)aBacteria 
HMWCOsb MMWCOSsc LMWCOSsd
Escheria colic
Escheria coli O-157c
Salmonella typhie
Pseudomonas aeruginosae
Streptococcus mutansf
Straphylococcus aureusf
Straphylococcus epidermidisf
Bacillus subtilisf
Micrococcus luteusf
98 
71 
91 
47 
100 
97 
82 
63 
70 
62 
56 
88 
35 
99 
95 
57 
60 
67 
51 
60 
89 
22 
99 
93 
23 
63 
63 
aFollowing the incubation of bacterial culture with 0.1% different COSs fractions, the number of colonies formed on the 
medium was calculated as a percentage compared to the control.  Maximum standard deviation from mean values reported 
was 10%. 
bHigh molecular weight chitosan oligosaccharides (molecular weight range 10-5 kDa). 
cMedium molecular weight chitosan oligosaccharides (molecular weight range 5-1 kDa). 
dLow molecular weight chitosan oligosaccharides (molecular weight below than 1 kDa). 
eGram-negative. 
fGram-positive. 
monomer of chitin, N-acetylglucosamine (NAG), has 
been shown to possess anti-inflammatory properties.  
Meanwhile, glucosamine, the monomer of chitosan, 
prepared via HCl hydrolysis, is marketed as 
glucosamine sulfate.  This formulation is prepared by 
addition of ferrous sulfate to the preparation.  
Glucosamine products may also be sold in 
formulations containing chondroitin sulfates.  While 
glucosamine helps to form proteoglycans that sit 
within the space in the cartilage, chondroitin sulfate 
acts like a liquid magnet.  Thus glucosamine and 
chondroitin work in a complementary manner to 
improve the health of the joint cartilage. 
The byproducts in chitin extraction process from 
shellfish include carotenoids/carotenoproteins, and 
enzymes [Shahidi and Kamil, 2001; Simpson, 2007; 
Simpson et al, 1991; Shahidi et al, 1998].  These 
components may also be isolated for further utilization 
in a variety of applications. 
ENZYMES 
The aquatic environment contains a wide range of 
genetic material and hence represents exciting 
potential for discovering different enzymes [Raa, 
1990].  Therefore, much effort has been made to 
recover and characterize enzymes from fish and 
aquatic invertebrates [Shahidi and Kamil, 2001].  
Digestive proteolytic enzymes from stomachless 
marine fish such as conner, crayfish and puffer appear 
to inactivate polyphenol oxidase and/or pectin esterase 
in fruit juices.  Successful application of such enzymes 
has also allowed inactivation of polyphenol oxidase in 
shrimp processing as an alternate to sulfiting 
[Simpson, 2007].  Alkaline phosphates from shrimp 
may be used in different diagnostic kits and some 
enzymes may be recovered and used in deskinning of 
fish and squid or cleaning of fish roe for caviar 
production, among others. 
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CAROTENOIDS 
Carotenoids and carotenoprotiens are present in 
salmonoid fish as well as in shellfish.  These 
carotenoids may be recovered from shellfish 
processing by-products and used in a variety of 
applications [Shahidi et al, 1998].  In addition, certain 
carotenoids, such as fucoxanthin occur naturally in 
seaweeds [Czeczuga and Taylor, 1987; Haugen and 
Liaeen-Jensen, 1994].  Fucoxanthin has been shown 
to have anti-proliferative activity on tumor cells and 
has also been implicated in having anti-obesity and 
anti-inflammatory effects.  Fucoxanthinol is a known 
metabolite of fucoxanthinol. 
MINERALS 
Among fish processing by-products, fish bone or 
skeleton (Figure 4) serves as a potential source of 
calcium which is an essential element for human 
health.  Calcium from fish would be easily absorbed by 
the body [Larsen et al, 2000].  However, to 
incorporate fish bone into calcium-fortified foods, it is 
necessary to first convert it into an edible form by 
softening its structure.  This could be achieved by hot 
water treatment and heat treatment in an acetic acid 
solution.  Pepsin-assisted degradation of Alaska 
Pollock bone in acetic acid solution led to highest 
degree of hydrolysis and dissolution of both mineral 
and organic parts of fish bone [Jung et al, 2005; 
Ishikawa, et al, 1990].  As reported by Larsen et al 
[2000], the intake of small fish with bones could 
increase calcium bioavailability.  Fish bone contains 
hydroxyapatite, which unlike other calcium phosphates 
does not break under physiological conditions and 
takes part in bone bonding.  This property has been 
exploited for rapid bone repair after major trauma or 
surgery. 
Figure 4: Fish bone after removal of proteins. 
OTHER BIOACTIVES FROM AQUATIC RESOURCES 
Seaweeds are a rich source of iodine, 
phlorotannins, glutathione, fucoxanthin and also 
carbohydrates such as alginates.  Much interest has 
also been expressed in algae because of 
epidemiological evidence has linked habitual 
consumption of seaweed to reduced risk of a number 
of chronic diseases in Japanese and Chinese 
population.  Fish skin may also be used for production 
of collagen as well as gelatin, the latter for special 
nutritional, religious and nutraceutical purposes.  
Meanwhile, unexploited aquatic resources from the 
oceans offer many opportunities for future 
developments. 
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